Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UMC Utrecht
Thomas Jefferson University
Alliance for Clinical Trials in Oncology
Tetra Bio-Pharma
Masonic Cancer Center, University of Minnesota
Northwestern University
Virginia Commonwealth University
Vanderbilt-Ingram Cancer Center